What's New


License Agreement Has Been Entered with Novoheart Limited

We executed a non-exclusive license agreement with Novoheart Limited (Hong Kong) for providing their products and services related to iPS cells and iPS cell-derived cardiomyocytes for research use, on the patents related to iPS cell technology that have been sublicensed to us by Kyoto University.


Back to top